Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

The International Medical Derm Summit 2025 highlighted China's dermatological advancements, fostering global collaboration ...

One in 10 people with atopic dermatitis, the most common type of eczema, have symptoms on their feet. These quick facts can help you manage it.

With few real-life studies that have specifically focused on how atopic dermatitis (AD) affects patients living with the ...

Patients with AD treated with dupilumab have a lower risk of various infections than those treated with methotrexate or cyclosporine.

Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), ...

Apogee Therapeutics said its antibody treatment alleviated signs and symptoms of atopic dermatitis far more than a placebo — ...

Intermittent treatment with pimecrolimus over 1 year significantly reverses corticosteroid-induced skin atrophy and ...

Findings from a recent phase 3b/4 study of upadacitinib support a treat-to-target strategy for dose escalation or reduction ...

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.